Taras Krytskyy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taras Krytskyy has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Nadiya Pasyechko
I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
9 shared publications - Liudmyla Naumova
I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
6 shared publications - A. M. Urbanovych
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
2 shared publications - A. O. Bob
I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE
2 shared publications - A.H. Haletska
V.P. Komisarenko Institute of Endocrinology and Metabolism of NAMSU, Kyiv, Ukraine
2 shared publications - Alan R. Shuldiner
Regeneron Genetics Center, Tarrytown, USA
2 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 20
Correction: A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe
- 24 October 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 20
Open AccessCorrection: A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe
- Open Access
- 30 September 2026
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 48-52
The impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes mellitus: the role of continuous glucose monitoring systems and artificial pancreas
The aim — to evaluate the impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes using data from continuous glucose monitoring systems and artificial pancreas systems. Materials and methods. The study included 62 patients with type 1 diabetes who used CGM systems for at least 14 days. Patients were divided into two groups: a high genetic risk group, which included patients with HLA-DR3/DR4 alleles and ≥ 2 autoantibodies, and a low genetic risk group, which included patients without these markers. Glycemic control was assessed using Time in Range and coefficient of variation metrics, which reflect glucose level stability. Genetic and immunological markers were identified using polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). Results. Patients with high genetic risk had significantly lower TIR values (52.1±10.8%) than patients with low genetic risk (61.3±11.2%). Furthermore, the high-risk group exhibited higher glucose variability, as evidenced by an increased CV (39.2±6.5%), compared to the low-risk group (CV — 33.8±5.9%). Multivariate linear regression analysis showed that the presence of HLA-DR3/DR4 and ≥ 2 autoantibodies were independent predictors of reduced TIR and increased CV. Conclusions. Genetic factors have a significant impact on glycemic stability in patients with type 1 diabetes mellitus. Patients with high genetic risk, characterized by the presence of HLA-DR3/DR4 alleles and ³ 2 autoantibodies, demonstrated poorer glycemic control, including lower Time in Range and higher coefficient of variation. This highlights the importance of an individualized approach to treatment and monitoring of these patients. The use of CGM and APS technologies cannot fully compensate for the impact of genetic factors, requiring adjustments in insulin therapy and continuous monitoring.
- 30 September 2026
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 3,p. 48-52
Open AccessThe impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes mellitus: the role of continuous glucose monitoring systems and artificial pancreas
The aim — to evaluate the impact of genetic and immunological factors on glycemic stability in patients with type 1 diabetes using data from continuous glucose monitoring systems and artificial pancreas systems. Materials and methods. The study included 62 patients with type 1 diabetes who used CGM systems for at least 14 days. Patients were divided into two groups: a high genetic risk group, which included patients with HLA-DR3/DR4 alleles and ≥ 2 autoantibodies, and a low genetic risk group, which included patients without these markers. Glycemic control was assessed using Time in Range and coefficient of variation metrics, which reflect glucose level stability. Genetic and immunological markers were identified using polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). Results. Patients with high genetic risk had significantly lower TIR values (52.1±10.8%) than patients with low genetic risk (61.3±11.2%). Furthermore, the high-risk group exhibited higher glucose variability, as evidenced by an increased CV (39.2±6.5%), compared to the low-risk group (CV — 33.8±5.9%). Multivariate linear regression analysis showed that the presence of HLA-DR3/DR4 and ≥ 2 autoantibodies were independent predictors of reduced TIR and increased CV. Conclusions. Genetic factors have a significant impact on glycemic stability in patients with type 1 diabetes mellitus. Patients with high genetic risk, characterized by the presence of HLA-DR3/DR4 alleles and ³ 2 autoantibodies, demonstrated poorer glycemic control, including lower Time in Range and higher coefficient of variation. This highlights the importance of an individualized approach to treatment and monitoring of these patients. The use of CGM and APS technologies cannot fully compensate for the impact of genetic factors, requiring adjustments in insulin therapy and continuous monitoring.
- Open Access
- 18 September 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 14
A collaborative genomics platform for type 1 diabetes in Eastern and Central Europe
- 18 September 2026
- Published by Springer Nature in Metabologia
- Vol. 2 (1) , 14
Open AccessA collaborative genomics platform for type 1 diabetes in Eastern and Central Europe
- Open Access
- 28 May 2026
- Published by Higher State Educational Establishment of Ukraine Bukovinian State Medical University in Bukovinian Medical Herald
- Vol. 30 (2 (118)) , 30-35
THE EFFECT OF CONTINUOUS GLUCOSE MONITORING ON GLYCAEMIC CONTROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE DURING WAR
Resume. Diabetes mellitus is one of the biggest health problems worldwide, significantly increasing the risk of developing cardiovascular diseases. To maintain effective glycaemic control and prevent cardiovascular complications, especially in settings with limited access to medical resources, the role of emerging technologies such as continuous glucose monitoring is growing. This technology allows patients and doctors to monitor glucose levels in real time, which is important for ensuring stable treatment even in difficult conditions.The aim of the study is to evaluate the impact of continuous glucose monitoring on glycemic control indicators, particularly HbA1c dynamics, and cardiovascular events in patients with diabetes mellitus (DM) and concomitant cardiovascular pathology under the conditions of martial law in Ukraine. Materials and methods. A prospective single-center study included 100 patients with type 1 and type 2 diabetes who were treated in the endocrinology and cardiology department of the Ternopil Regional Clinical Hospital in 2023-2024. All patients were equipped with CGM systems. HbA1c, Time in Range (TIR), Time Above Range (TAR), Time Below Range (TBR), glycemic variability (%CV), frequency of hypoglycemic events, and cardiovascular events were evaluated.Results. After 12 weeks of CGM use, there was a statistically significant reduction in HbA1c (from 8.6% to 7.4%; p<0.001), an increase in TIR (from 51% to 72%; p<0.001), and a decrease in the frequency of hypoglycemic events and hospitalizations for acute cardiovascular events. The use of CGM was associated with a reduction in glycemic variability and subjective stress levels.Conclusions. Continuous glucose monitoring is an effective tool for improving diabetes control and preventing cardiovascular complications in high-risk patients under wartime conditions. The dynamics of HbA1c reflect the integrated positive impact of CGM on the glycemic profile.
- 28 May 2026
- Published by Higher State Educational Establishment of Ukraine Bukovinian State Medical University in Bukovinian Medical Herald
- Vol. 30 (2 (118)) , 30-35
Open AccessTHE EFFECT OF CONTINUOUS GLUCOSE MONITORING ON GLYCAEMIC CONTROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES AND CARDIOVASCULAR DISEASE DURING WAR
Resume. Diabetes mellitus is one of the biggest health problems worldwide, significantly increasing the risk of developing cardiovascular diseases. To maintain effective glycaemic control and prevent cardiovascular complications, especially in settings with limited access to medical resources, the role of emerging technologies such as continuous glucose monitoring is growing. This technology allows patients and doctors to monitor glucose levels in real time, which is important for ensuring stable treatment even in difficult conditions.The aim of the study is to evaluate the impact of continuous glucose monitoring on glycemic control indicators, particularly HbA1c dynamics, and cardiovascular events in patients with diabetes mellitus (DM) and concomitant cardiovascular pathology under the conditions of martial law in Ukraine. Materials and methods. A prospective single-center study included 100 patients with type 1 and type 2 diabetes who were treated in the endocrinology and cardiology department of the Ternopil Regional Clinical Hospital in 2023-2024. All patients were equipped with CGM systems. HbA1c, Time in Range (TIR), Time Above Range (TAR), Time Below Range (TBR), glycemic variability (%CV), frequency of hypoglycemic events, and cardiovascular events were evaluated.Results. After 12 weeks of CGM use, there was a statistically significant reduction in HbA1c (from 8.6% to 7.4%; p<0.001), an increase in TIR (from 51% to 72%; p<0.001), and a decrease in the frequency of hypoglycemic events and hospitalizations for acute cardiovascular events. The use of CGM was associated with a reduction in glycemic variability and subjective stress levels.Conclusions. Continuous glucose monitoring is an effective tool for improving diabetes control and preventing cardiovascular complications in high-risk patients under wartime conditions. The dynamics of HbA1c reflect the integrated positive impact of CGM on the glycemic profile.
- Open Access
- 31 March 2026
- Published by Professional Event, LLC in Health of Man
- No. 1,p. 75-81
The Quality of Life Assessment and Psychological and Emotional State of Patients with Diabetes Mellitus and Cardiovascular Disease in War Conditions
Type 2 diabetes mellitus and cardiovascular diseases (CVDs) are among the most common chronic diseases that significantly impair patients’ quality of life and increase the risk of serious complications. The objective. To assess the psychoemotional state, in particular the level of anxiety, depressive symptoms, stress, and quality of life in patients with type 2 diabetes mellitus and CVDs. Materials and methods. The study was conducted at the endocrinology and cardiology departments of the Ternopil Regional Hospital from 2021 to 2024. The study involved 78 male patients aged 30 to 60 with type II diabetes and/or CVD. The psychological and emotional state was assessed using the GAD-7 (anxiety level), BDI (depressive symptoms) scales and the Holmes and Rahe methods for determining stress resistance. The quality of life of patients was assessed using the SF-36 questionnaire. Results. The results showed a significant decrease in quality of life and stress resistance, as well as an increase in depression and anxiety levels in patients with a combination of type 2 diabetes and CVD compared to patients suffering from only one of these diseases. Patients with comorbidities experienced a significant increase in psychological and emotional stress, indicating the need for a comprehensive approach to treatment, including psychological and emotional support. The psychological and emotional state of patients has a significant impact on their quality of life and the effectiveness of therapy. Conclusions. Increased levels of stress, depression, and anxiety contribute to the deterioration of patients’ overall condition, reduce their ability to cope with chronic diseases, and complicate treatment. It is necessary to integrate psychotherapeutic strategies into the therapeutic process. Further research should focus on the implementation of effective psychotherapeutic techniques aimed at reducing the psychoemotional burden in patients with comorbidities.
- 31 March 2026
- Published by Professional Event, LLC in Health of Man
- No. 1,p. 75-81
Open AccessThe Quality of Life Assessment and Psychological and Emotional State of Patients with Diabetes Mellitus and Cardiovascular Disease in War Conditions
Type 2 diabetes mellitus and cardiovascular diseases (CVDs) are among the most common chronic diseases that significantly impair patients’ quality of life and increase the risk of serious complications. The objective. To assess the psychoemotional state, in particular the level of anxiety, depressive symptoms, stress, and quality of life in patients with type 2 diabetes mellitus and CVDs. Materials and methods. The study was conducted at the endocrinology and cardiology departments of the Ternopil Regional Hospital from 2021 to 2024. The study involved 78 male patients aged 30 to 60 with type II diabetes and/or CVD. The psychological and emotional state was assessed using the GAD-7 (anxiety level), BDI (depressive symptoms) scales and the Holmes and Rahe methods for determining stress resistance. The quality of life of patients was assessed using the SF-36 questionnaire. Results. The results showed a significant decrease in quality of life and stress resistance, as well as an increase in depression and anxiety levels in patients with a combination of type 2 diabetes and CVD compared to patients suffering from only one of these diseases. Patients with comorbidities experienced a significant increase in psychological and emotional stress, indicating the need for a comprehensive approach to treatment, including psychological and emotional support. The psychological and emotional state of patients has a significant impact on their quality of life and the effectiveness of therapy. Conclusions. Increased levels of stress, depression, and anxiety contribute to the deterioration of patients’ overall condition, reduce their ability to cope with chronic diseases, and complicate treatment. It is necessary to integrate psychotherapeutic strategies into the therapeutic process. Further research should focus on the implementation of effective psychotherapeutic techniques aimed at reducing the psychoemotional burden in patients with comorbidities.
- 4 March 2026
- Published by LLC MORION in Ukrainian Medical Journal
Assessment of the impact of nocturnal hyperglycemia and glycemic variability on cardiovascular risk in patients with type 2 diabetes mellitus. The role of continuous glucose monitoring
The prevalence of diabetes mellitus is among the significant medical and social issues of the world, and cardiovascular disease is the main cause of mortality in patients with diabetes. The increasing population of patients with type 2 diabetes, and the necessity to comprehend the correlation of glycaemic control and cardiovascular complications are influencing the development of new practices in the risk assessment of such patients. The customary technique of determining the glycaemic control by means of the glycated haemoglobin (HbA1c) level fails to include key points like the changes in the glucose levels during the day have the potential to raise the risk of cardiovascular problems. Evidence demonstrates that glycaemic variability, which is the presence of nocturnal blood glucose variability, exert a considerable pathophysiological effect on the progression of atherosclerosis and other conditions of the vascular structures. Aim: to assess how nocturnal hyperglycaemia and glycaemic variability contribute to cardiovascular risk among diabetic type 2 patients. Object and methods of the research. This research was done in the Ternopil Regional Hospital on 50 type 2 diabetes patients between the ages of 40 and 75 years. Each and every patient was monitored through continuous glucose monitoring (CGM) of at least 10 days. Nocturnal glycaemic parameters analysed with CGM included time in range, time above/below range and glycaemic variability. The cardiovascular risk factors such as blood pressure, lipids profile and the HbA1c were measured also. Results. These findings demonstrated that patients with type 2 diabetes tend to experience night-time hyperglycaemia and 62 per cent of the patients experienced a night time TIR of less than the recommended 70 per cent. This was linked with high systolic blood pressure and deteriorated lipid profile. Greater glycaemic variability was linked to greater cardiovascular risk and related with the oxidative stress and atherosclerosis development. The results of multiple regression analysis revealed that Night-time TIR 36%, MAGE >5.0 mmol/L are independent predictors of high cardiovascular risk, regardless of other variables. Conclusion. The results of the obtained data support the significance of measuring night-time glycaemic parameters and glycaemic change in improving the evaluation of cardiovascular risk among patients with type 2 diabetes mellitus. Considering the high importance of nocturnal hyperglycaemia effects on metabolic and haemodynamic parameters, CGM should be introduced in clinical practice in order to control glycaemia and cardiovascular complications better.
- 4 March 2026
- Published by LLC MORION in Ukrainian Medical Journal
Assessment of the impact of nocturnal hyperglycemia and glycemic variability on cardiovascular risk in patients with type 2 diabetes mellitus. The role of continuous glucose monitoring
The prevalence of diabetes mellitus is among the significant medical and social issues of the world, and cardiovascular disease is the main cause of mortality in patients with diabetes. The increasing population of patients with type 2 diabetes, and the necessity to comprehend the correlation of glycaemic control and cardiovascular complications are influencing the development of new practices in the risk assessment of such patients. The customary technique of determining the glycaemic control by means of the glycated haemoglobin (HbA1c) level fails to include key points like the changes in the glucose levels during the day have the potential to raise the risk of cardiovascular problems. Evidence demonstrates that glycaemic variability, which is the presence of nocturnal blood glucose variability, exert a considerable pathophysiological effect on the progression of atherosclerosis and other conditions of the vascular structures. Aim: to assess how nocturnal hyperglycaemia and glycaemic variability contribute to cardiovascular risk among diabetic type 2 patients. Object and methods of the research. This research was done in the Ternopil Regional Hospital on 50 type 2 diabetes patients between the ages of 40 and 75 years. Each and every patient was monitored through continuous glucose monitoring (CGM) of at least 10 days. Nocturnal glycaemic parameters analysed with CGM included time in range, time above/below range and glycaemic variability. The cardiovascular risk factors such as blood pressure, lipids profile and the HbA1c were measured also. Results. These findings demonstrated that patients with type 2 diabetes tend to experience night-time hyperglycaemia and 62 per cent of the patients experienced a night time TIR of less than the recommended 70 per cent. This was linked with high systolic blood pressure and deteriorated lipid profile. Greater glycaemic variability was linked to greater cardiovascular risk and related with the oxidative stress and atherosclerosis development. The results of multiple regression analysis revealed that Night-time TIR 36%, MAGE >5.0 mmol/L are independent predictors of high cardiovascular risk, regardless of other variables. Conclusion. The results of the obtained data support the significance of measuring night-time glycaemic parameters and glycaemic change in improving the evaluation of cardiovascular risk among patients with type 2 diabetes mellitus. Considering the high importance of nocturnal hyperglycaemia effects on metabolic and haemodynamic parameters, CGM should be introduced in clinical practice in order to control glycaemia and cardiovascular complications better.
- Open Access
- 25 June 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (4) , 374-380
Innovative approaches to the management of patients with obstructive sleep apnea-hypopnea syndrome, obesity and hypertension
Background. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by recurrent episodes of partial or complete upper airway collapse during sleep that is highlighted by a reduction or complete cessation of airflow despite documented ongoing inspiratory efforts. There are some pharmacological treatments for daytime sleepiness caused by OSASH. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications. The purpose of the study was to determine the functional state of the cardiovascular system and the oxygen state of body tissues in patients with OSAHS of varying severity. Materials and methods. The study included 109 participants (85 men and 24 women) aged 27 to 55 (mean of 46.4 ± 9.1) years. All patients were comparable in sex, age, anthropometric parameters, as well as in the history of hypertension and the level of office blood pressure and underwent a study of the oxygen state by pulse oximetry and oximetry. Results. Hypertension in patients with obstructive sleep apnea-hypopnea syndrome is more resistant to therapy. The degree of resistance depends on the severity of OSAHS. The analysis of daily blood pressure monitoring data in OSAHS revealed differences in the growth of mean blood pressure, hypertension time index and daily blood pressure profile. The degree of night blood pressure reduction in patients with severe OSAHS was lower, among them, individuals with non-dipper and night-peaker profiles predominated. Conclusions. In OSAHS, significant disorders of arterial and venous blood oxygenation were detected, which is confirmed by a reliable decrease in venous blood saturation (p < 0.01) and oxygen content in arterial blood (p < 0.01). The volume of oxygen consumed by peripheral tissues was significantly lower (p < 0.05) in patients with severe OSAHS.
- 25 June 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (4) , 374-380
Open AccessInnovative approaches to the management of patients with obstructive sleep apnea-hypopnea syndrome, obesity and hypertension
Background. Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by recurrent episodes of partial or complete upper airway collapse during sleep that is highlighted by a reduction or complete cessation of airflow despite documented ongoing inspiratory efforts. There are some pharmacological treatments for daytime sleepiness caused by OSASH. Identifying and treating obstructive sleep apnea early is important to reduce the risks of future complications. The purpose of the study was to determine the functional state of the cardiovascular system and the oxygen state of body tissues in patients with OSAHS of varying severity. Materials and methods. The study included 109 participants (85 men and 24 women) aged 27 to 55 (mean of 46.4 ± 9.1) years. All patients were comparable in sex, age, anthropometric parameters, as well as in the history of hypertension and the level of office blood pressure and underwent a study of the oxygen state by pulse oximetry and oximetry. Results. Hypertension in patients with obstructive sleep apnea-hypopnea syndrome is more resistant to therapy. The degree of resistance depends on the severity of OSAHS. The analysis of daily blood pressure monitoring data in OSAHS revealed differences in the growth of mean blood pressure, hypertension time index and daily blood pressure profile. The degree of night blood pressure reduction in patients with severe OSAHS was lower, among them, individuals with non-dipper and night-peaker profiles predominated. Conclusions. In OSAHS, significant disorders of arterial and venous blood oxygenation were detected, which is confirmed by a reliable decrease in venous blood saturation (p < 0.01) and oxygen content in arterial blood (p < 0.01). The volume of oxygen consumed by peripheral tissues was significantly lower (p < 0.05) in patients with severe OSAHS.
- Open Access
- 15 December 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 79, 103008
The impact of war on people with type 2 diabetes in Ukraine: a survey study
- 15 December 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 79, 103008
Open AccessThe impact of war on people with type 2 diabetes in Ukraine: a survey study
- Open Access
- 27 September 2024
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 20 (5) , 370-374
Medical information retrieval systems in diabetes management
Background. Medical information retrieval is becoming more crucial as a way to support decision-making and improve access to knowledge and information for doctors and other specialists in the field. By the incorporation of medical domain knowledge for relevance evaluation, integrating the medical knowledge bases has the potential to enhance information retrieval performance. The system uses various search algorithms and techniques to provide accurate and comprehensive results to medical professionals and researchers. Medical information retrieval systems are particularly useful for healthcare providers who need to stay up-to-date with the latest medical research, guidelines, and treatment options. The purpose was to study the use of medical information systems to improve the quality of medical care for patients with diabetes. Materials and methods. To assess the relevance of research using information systems in the SCOPUS database, an analytical query was formulated: ALL (“Diabetes”) AND (ALL (“Constant monitoring of glucose”) OR ALL (“Coefficient of variability of glucose”) OR ALL (“Time in the given target range”) OR ALL (“Time above range”) OR ALL (“Time below range”) OR ALL (“Insulin pump”). A search query on this topic found 17,532 scientific papers from 1974 to 2023. Results. The largest number of literary sources on the researched topic falls on 2014–2023. During this period, 10,531 works were published. In 2014, 728 papers were published, and in 2023 — 1,499 papers, which confirms the constant growth of interest and relevance in improving medical care for patients with diabetes worldwide. Since the statistics show a steady annual increase in the number of patients with diabetes, the search for effective methods of control and treatment of this nosology is extremely urgent. Conclusions. The implementation of medical information systems in diabetology has significant potential and can significantly improve the control and management of the disease, increase not only the duration, but also the quality of life of patients and optimize the work of medical personnel.
- 27 September 2024
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 20 (5) , 370-374
Open AccessMedical information retrieval systems in diabetes management
Background. Medical information retrieval is becoming more crucial as a way to support decision-making and improve access to knowledge and information for doctors and other specialists in the field. By the incorporation of medical domain knowledge for relevance evaluation, integrating the medical knowledge bases has the potential to enhance information retrieval performance. The system uses various search algorithms and techniques to provide accurate and comprehensive results to medical professionals and researchers. Medical information retrieval systems are particularly useful for healthcare providers who need to stay up-to-date with the latest medical research, guidelines, and treatment options. The purpose was to study the use of medical information systems to improve the quality of medical care for patients with diabetes. Materials and methods. To assess the relevance of research using information systems in the SCOPUS database, an analytical query was formulated: ALL (“Diabetes”) AND (ALL (“Constant monitoring of glucose”) OR ALL (“Coefficient of variability of glucose”) OR ALL (“Time in the given target range”) OR ALL (“Time above range”) OR ALL (“Time below range”) OR ALL (“Insulin pump”). A search query on this topic found 17,532 scientific papers from 1974 to 2023. Results. The largest number of literary sources on the researched topic falls on 2014–2023. During this period, 10,531 works were published. In 2014, 728 papers were published, and in 2023 — 1,499 papers, which confirms the constant growth of interest and relevance in improving medical care for patients with diabetes worldwide. Since the statistics show a steady annual increase in the number of patients with diabetes, the search for effective methods of control and treatment of this nosology is extremely urgent. Conclusions. The implementation of medical information systems in diabetology has significant potential and can significantly improve the control and management of the disease, increase not only the duration, but also the quality of life of patients and optimize the work of medical personnel.
- Open Access
- 30 March 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 51-55
Fat-shaming or stigmatization of obesity. Literature review
The literature review is devoted to stigmatization — the imposition of social labels. A person with excess body weight is considered by most people to be weak, lazy, spiritless, unsuccessful. In recent years, the topic of stigmatization of obesity began to be studied not only in society, but also in medical institutions. People suffering from obesity feel judged, rejected by others on the street, in public transport, in educational institutions, at work, in the store. More importantly, overweight patients feel disadvantaged and often even judged by their doctors. At the same time, doctors usually do not realize the stigmatization of obesity, the relevance of this topic and the importance of discussing it with the patient. As a result, the patient cancels consultations and even interrupts treatment. Ultimately, all this contributes to an increase in body weight and increases the likelihood of the appearance of new obesity‑related diseases and even the emergence of critical psychological conditions. Despite the fact that the problem of obesity has been known since ancient times, only in the last few years it has been recognized as a chronic and continuously relapsing disease. And later came an understanding of the need to eradicate stigma and discrimination of people because of their weight. Stigma in translation means a stigma with which we often «award» patients with various diseases: such as a hypertensive diabetic. Patients with comorbid pathology against the background of obesity become even more vulnerable and sensitive not only to the words of the medical staff, but also to the people around them. Stigmatization of obesity is stressful for all patients, which can lead to feelings of shame, guilt, failure, and fear. Fear is accompanied by the release of cortisol, and one way to overcome fear or stress is to use food as a distraction. Thus, a vicious circle is formed: stigma‑stress‑increased cortisol level‑eating more food‑gaining weight‑obesity‑stigmatization of obesity.
- 30 March 2024
- Published by Publishing Company VIT-A-POL in Clinical endocrinology and endocrine surgery
- No. 1,p. 51-55
Open AccessFat-shaming or stigmatization of obesity. Literature review
The literature review is devoted to stigmatization — the imposition of social labels. A person with excess body weight is considered by most people to be weak, lazy, spiritless, unsuccessful. In recent years, the topic of stigmatization of obesity began to be studied not only in society, but also in medical institutions. People suffering from obesity feel judged, rejected by others on the street, in public transport, in educational institutions, at work, in the store. More importantly, overweight patients feel disadvantaged and often even judged by their doctors. At the same time, doctors usually do not realize the stigmatization of obesity, the relevance of this topic and the importance of discussing it with the patient. As a result, the patient cancels consultations and even interrupts treatment. Ultimately, all this contributes to an increase in body weight and increases the likelihood of the appearance of new obesity‑related diseases and even the emergence of critical psychological conditions. Despite the fact that the problem of obesity has been known since ancient times, only in the last few years it has been recognized as a chronic and continuously relapsing disease. And later came an understanding of the need to eradicate stigma and discrimination of people because of their weight. Stigma in translation means a stigma with which we often «award» patients with various diseases: such as a hypertensive diabetic. Patients with comorbid pathology against the background of obesity become even more vulnerable and sensitive not only to the words of the medical staff, but also to the people around them. Stigmatization of obesity is stressful for all patients, which can lead to feelings of shame, guilt, failure, and fear. Fear is accompanied by the release of cortisol, and one way to overcome fear or stress is to use food as a distraction. Thus, a vicious circle is formed: stigma‑stress‑increased cortisol level‑eating more food‑gaining weight‑obesity‑stigmatization of obesity.